HTHideo Takayama

Hideo Takayama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hideo Takayama has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Kouki Nio

    Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan

    3 shared publications
  • Masashi Nishikawa

    NHO Kanazawa Medical Center Division of Gastroenterology 1-1 Shimoishibikimachi, Kanazawa, Ishikawa 920-0939, Japan

    3 shared publications
  • Masashi Unoura

    Division of Gastroenterology NHO, Kanazawa Medical Center, 1-1 Shimoishibikimachi, Kanazawa, Ishikawa 920-8650, Japan

    3 shared publications
  • Saiho Sugimoto

    Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa University

    3 shared publications
  • Saiho Sugimoto

    Department of Gastroenterology, Graduate School of Medicine, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-8641, Japan

    3 shared publications
  • Shuichi Kaneko

    Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan

    3 shared publications

Latest Publications

  • Open Access

    DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanism

    by Hideo Takayama, Kouki Nio, Kazuyuki Kuroki, Ying-Yi Li, Saiho Sugimoto, Tetsuro Shimakami, Kazuhisa Murai, Kazunori Kawaguchi, Takumi Nishiuchi, Shuichi Kaneko, et al.

    Hepatitis B virus (HBV) infection remains a major global health concern due to the persistence of covalently closed circular DNA (cccDNA) in the hepatocyte nucleus, which contributes to viral persistence and hepatocarcinogenesis despite antiviral therapy. Poly(ADP-ribose) polymerase 1 (PARP1) has been reported to bind to HBV relaxed circular DNA (rcDNA) and contribute to the conversion of rcDNA to cccDNA. We previously identified dedicator of cytokinesis 11 (DOCK11) as a host factor whose suppression reduced cccDNA levels in HBV infection models; however, the precise role of DOCK11 in the process of cccDNA formation remains unclear. In this study, we investigated the role of DOCK11 in HBV cccDNA formation and the underlying mechanisms. Using a minicircle HBV cccDNA reporter, we observed that luciferase activity declined significantly in DOCK11-depleted hepatoma cells over time, consistent with impaired cccDNA maintenance. In a cell-free assay using rcDNA and nuclear extracts, DOCK11 overexpression significantly enhanced cccDNA formation, while DOCK11 knockout significantly suppressed it. Co-immunoprecipitation suggested that DOCK11 forms a multiprotein complex with HBV DNA. Furthermore, liquid chromatography-mass spectrometry analysis identified PARP1 as a significant component of this complex. Notably, while DOCK11 did not affect PARP1 expression or enzymatic activity, DOCK11 knockout significantly reduced PARP1 recruitment to UV-irradiated DNA damage sites and its association with rcDNA, suggesting a supportive role for DOCK11 in PARP1 recruitment to rcDNA. In summary, DOCK11 promotes HBV cccDNA formation, possibly through its interaction with HBV DNA and PARP1. These findings position DOCK11 as a promising therapeutic target for cccDNA reduction in chronic HBV infection. IMPORTANCE: Hepatitis B virus (HBV) causes chronic liver infection, affecting hundreds of millions of people worldwide and increasing the risk of cirrhosis and hepatocellular carcinoma. Persistent HBV infection is maintained by covalently closed circular DNA (cccDNA), which is resistant to current antiviral therapies. Understanding cccDNA maintenance mechanisms, including cccDNA formation, is therefore critical for developing curative treatments. Poly(ADP-ribose) polymerase 1 (PARP1) is known to bind HBV relaxed circular DNA (rcDNA) and contribute to the conversion of rcDNA to cccDNA. In this study, we identified the host protein dedicator of cytokinesis 11 as a host regulator of HBV cccDNA formation through its interaction with PARP1, an enzyme involved in DNA repair. Our findings reveal a previously unrecognized mechanism by which HBV exploits host cellular machinery to persist in hepatocytes. By inhibiting this pathway, our work highlights potential targets for novel therapies aimed at eliminating cccDNA and achieving a functional cure for HBV infection.


  • Advanced poorly differentiated gallbladder carcinoma with focal poorly cohesive and signet-ring cell features

    by Hideo Takayama, Ryoka Masuda, Kohei Yasuda, Kaori Yoshimura, Kiichiro Kaji, Kuniaki Arai, Kenichi Harada, Taro Yamashita, Shuichi Terasaki

    Cases of gallbladder carcinoma containing poorly cohesive and signet-ring cell components are extremely rare, and their clinical characteristics remain unclear. We report a case involving a 70-year-old man who presented with fever and abdominal pain. Imaging at admission revealed diffuse gallbladder wall thickening and peritoneal metastatic nodules around the gallbladder, leading to a diagnosis of advanced gallbladder carcinoma; however, concurrent cholecystitis was suspected because of persistent fever and elevated inflammatory markers. The patient showed no response to antimicrobial therapy or gallbladder drainage, raising concern for tumor-associated inflammation and cancer-related pain. Bile cytology did not yield a definitive diagnosis; the patient showed unusually rapid enlargement of peritoneal metastases and died 2 months after presentation. Autopsy with immunohistopathological analysis confirmed advanced poorly differentiated gallbladder carcinoma with focal poorly cohesive and signet-ring cell features. This case illustrates that rare histological subtypes of gallbladder carcinoma may progress rapidly with extensive peritoneal metastatic nodules. Moreover, in such atypical variants of gallbladder carcinoma, early consideration of oncologic treatment is important while simultaneously controlling the infection.

  • Open Access

    Colonic Malakoplakia With an Adenomatous Appearance on Magnification Endoscopy: A Case Report

    by Shima Sono, Kiichiro Kaji, Miyabi Miura, Hideo Takayama, Kohei Yasuda, Kuniaki Arai, Kenichi Harada, Shuichi Terasaki

    Malakoplakia is a rare chronic granulomatous disease associated with impaired macrophage phagocytosis of bacteria. Because colonic malakoplakia presents with varied endoscopic appearances, its characteristic features have not been clearly defined, and differentiation from colorectal neoplasms during endoscopy may be difficult. We report a case of colonic malakoplakia with adenomatous features evaluated using magnifying narrow‐band imaging (NBI). A patient receiving hemodialysis and corticosteroid therapy for immunoglobulin A nephropathy underwent total colonoscopy after a positive fecal immunochemical test. Two reddish polyps were identified in the ascending colon. Magnifying NBI showed either absent or regular surface patterns with fine, thread‐like vessels, along with areas resembling adenomatous changes. Although malignant features were not observed, a definitive diagnosis could not be established endoscopically. Consequently, both lesions were resected using cold snare polypectomy. Histopathological examination revealed a granulation tissue‐like inflammatory lesion composed of histiocytes containing Michaelis–Gutmann bodies in the lamina propria and submucosa, leading to a diagnosis of malakoplakia. Based on this diagnosis, a surveillance colonoscopy was scheduled for 1 year later.

  • Open Access

    A case of acute lithium poisoning and hypermagnesemia involving advanced colon cancer-induced colonic obstruction

    by Hideo Takayama, Takuya Komura, Taro Kawane, Toshiki Matsuo, Makiko Kimura, Masashi Nishikawa, Kiyoki Kitagawa, Wataru Omi, Kenichi Sakajiri, Ichiro Onishi, et al.

    An 83-year-old woman presented with disturbance of consciousness and hand tremor. She had taken lithium carbonate 300 mg/day for bipolar disorder and magnesium oxide 660 mg/day for constipation. Blood tests revealed lithium poisoning, hypermagnesemia and acute kidney injury. Computed tomography showed colonic obstruction caused by cancer of the descending colon. In the outpatient section, her blood pressure decreased to 89/54 mmHg, and her heart rate dropped to 40 bpm. We considered that the obstructive ileus induced intravascular dehydration, which led to toxic serum concentrations of lithium and magnesium, triggering the emergence of severe arrythmia induced by sinus dysfunction. The patient was treated with fluid resuscitation and hemodialysis, followed by endoscopic stent replacement for the descending colon cancer obstruction. These treatments improved her general condition and alleviated the lithium poisoning, hypermagnesemia and colonic obstruction. Such a case is considered extremely rare.


  • Open Access

    Functional involvement of endothelial lipase in hepatitis B virus infection

    by Takayoshi Shirasaki, Kazuhisa Murai, Atsuya Ishida, Kazuyuki Kuroki, Kazunori Kawaguchi, Ying Wang, Souma Yamanaka, Rio Yasukawa, Narumi Kawasaki, Ying-Yi Li, et al.

    Background: HBV infection causes chronic liver disease and leads to the development of HCC. To identify host factors that support the HBV life cycle, we previously established the HC1 cell line that maintains HBV infection and identified host genes required for HBV persistence. Methods: The present study focused on endothelial lipase (LIPG), which binds to heparan sulfate proteoglycans (HSPGs) in the cell membrane. Results: We found HBV infection was impaired in humanized liver chimeric mouse-derived hepatocytes that were transduced with lentivirus expressing short hairpin RNA against LIPG. Long-term suppression of LIPG combined with entecavir further suppressed HBV replication. LIPG was shown to be involved in HBV attachment to the cell surface by using 2 sodium taurocholate cotransporting peptide (NTCP)-expressing cell lines, and the direct interaction of LIPG and HBV large surface protein was revealed. Heparin and heparinase almost completely suppressed the LIPG-induced increase of HBV attachment, indicating that LIPG accelerated HBV attachment to HSPGs followed by HBV entry through NTCP. Surprisingly, the attachment of a fluorescently labeled NTCP-binding preS1 probe to NTCP-expressing cells was not impaired by heparin, suggesting the HSPG-independent attachment of the preS1 probe to NTCP. Interestingly, attachment of the preS1 probe was severely impaired in LIPG knockdown or knockout cells. Inhibitors of the lipase activity of LIPG similarly impaired the attachment of the preS1 probe to NTCP-expressing cells. Conclusions: LIPG participates in HBV infection by upregulating HBV attachment to the cell membrane by means of 2 possible mechanisms: increasing HBV attachment to HSPGs or facilitating HSPG-dependent or HSPG-independent HBV attachment to NTCP by its lipase activity. Export


  • Open Access

    Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors

    by Phuong Thi Bich Doan, Kouki Nio, Tetsuro Shimakami, Kazuyuki Kuroki, Ying-Yi Li, Saiho Sugimoto, Hideo Takayama, Hikari Okada, Shuichi Kaneko, Masao Honda, et al.

    Infection with hepatitis B virus (HBV) cannot be cured completely because of the persistence of covalently closed circular DNA (cccDNA). We previously found that the host gene dedicator of cytokinesis 11 (DOCK11) was required for HBV persistence. In this study, we further investigated the mechanism that links DOCK11 to other host genes in the regulation of cccDNA transcription. cccDNA levels were determined by quantitative real-time polymerase chain reaction (qPCR) and fluorescence in situ hybridization (FISH) in stable HBV-producing cell lines and HBV-infected PXB-cells®. Interactions between DOCK11 and other host genes were identified by super-resolution microscopy, immunoblotting, and chromatin immunoprecipitation. FISH facilitated the subcellular localization of key HBV nucleic acids. Interestingly, although DOCK11 partially colocalized with histone proteins, such as H3K4me3 and H3K27me3, and nonhistone proteins, such as RNA Pol II, it played limited roles in histone modification and RNA transcription. DOCK11 was functionally involved in regulating the subnuclear distribution of host factors and/or cccDNA, resulting in an increase in cccDNA closely located to H3K4me3 and RNA Pol II for activating cccDNA transcription. Thus, it was suggested that the association of cccDNA-bound Pol II and H3K4me3 required the assistance of DOCK11. DOCK11 facilitated the association of cccDNA with H3K4me3 and RNA Pol II.


  • Open Access

    Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B

    by Hideo Takayama, Takuya Komura, Takashi Kagaya, Saiho Sugimoto, Noriaki Orita, Yoshiro Asahina, Masashi Nishikawa, Hajime Ohta, Shuichi Kaneko, Masashi Unoura

    Aim. Hepatitis B virus (HBV) infection is a major public health concern worldwide. Entecavir (ETV), a first‐line nucleos(t)ide analogue (NA) for HBV, has a low risk of resistance. We evaluated the efficacy of ETV monotherapy, ratio of ETV‐resistant, and the clinical features of patients with ETV resistance. Methods. A total of 130 patients (72 males, 58 females; mean age, 61 ± 15 years) were divided into a NA‐naïve group (n = 108) and NA‐experienced group (n = 22). We examined the clinical outcomes of ETV monotherapy and associated factors. We also assessed the clinical features of 15 patients with resistance to ETV (mean, 51.0 ± 27.4 weeks). Results. Among the 130 patients, 94.1% achieved ALT normalization and 63.6% achieved serum HBV DNA negativity after ETV monotherapy for 96 weeks. Of the patients in the NA‐naïve group, 93.1% and 60.4% achieved ALT normalization and HBV DNA negativity, respectively. Of the patients in the NA‐experienced group, 100% and 74.9% achieved ALT normalization and HBV DNA negativity, respectively. Compared to patients on ETV continuously, 15 ETV‐resistant patients had a higher baseline HBV viral load. There was a significant difference in the time to HBV DNA negativity, but not ALT normalization after ETV monotherapy in these groups. Rescue treatment with other NAs led to ALT normalization in all of these patients, but not HBV DNA negativity. Conclusions. ETV monotherapy has a long‐term clinical efficacy. While some patients especially with HBV DNA high viral load developed ETV resistance, rescue treatment led to ALT normalization in these patients.


  • Imaging features and pathological evaluation by EUS-FNA enable conservative management in patient of lymphoepithelial cyst of the pancreas: a case report

    by Takuya Komura, Takashi Kagaya, Noriaki Orita, Hideo Takayama, Saiho Sugimoto, Yoshiro Asahina, Yuki Hattori, Masashi Nishikawa, Makiko Minami, Atsuhiro Kawashima, et al.

    Pancreatic lymphoepithelial cysts (LECs) are rare cystic lesions filled with a keratinous substance and lined by squamous epithelium with underlying lymphoid tissue. Because pancreatic LECs are entirely benign, correct preoperative diagnosis is important to avoid unnecessary surgery. However, the imaging features of pancreatic LECs are not specific and preoperative diagnosis has proven difficult. A pancreatic mass was incidentally detected through abdominal ultrasonography in a 63-year-old male presenting without any symptoms. Computed tomography showed an exophytic cystic lesion in the pancreatic head. The lesion had heterogeneous high signal intensity with partial low intensity on T2-weighted magnetic resonance imaging (MRI) and high signal intensity on diffusion MRI. Endoscopic ultrasound (EUS) examination showed an encapsulated cystic lesion with relatively homogenous and highly echoic contents. EUS-guided fine-needle aspiration (EUS-FNA) revealed caseous appearance and rare fragments of apparently benign squamous epithelium on a background of keratinous debris, cyst contents, and scattered lymphocytes. We diagnosed a pancreatic LEC and opted for conservative management without surgery. Pathological evaluation based on images obtained through EUS-FNA showed macro- and microscopic features that were critical to determining the management strategy. In conclusion, the imaging and pathological features of pancreatic LECs can inform preoperative diagnosis, which may enable conservative management.


  • Open Access

    Clinical Features and Dynamics of T Cells-Related Markers in Immunocompetent Patients with Cytomegalovirus Hepatitis

    by Takuya Komura, Takashi Kagaya, Hideo Takayama, Masahiro Yanagi, Takatoshi Yoshio, Saiho Sugimoto, Michiko Nishino, Noriaki Orita, Yoshiro Asahina, Masashi Nishikawa, et al.

    Aim. Cytomegalovirus (CMV) can cause hepatitis, encephalomyelitis, and pneumonitis in immunocompromised patients. In contrast, CMV infection of immunocompetent patients can lead to the development of infectious mononucleosis and is typically self-limiting; severe complications are rare. We evaluated the pathophysiology and immunological aspects of CMV hepatitis in recently immunocompetent adult patients. Methods. We examined the clinical features and outcomes of 47 adult immunocompetent patients with CMV hepatitis (29 men, 18 women; mean age, 34±11 years) from January 2005 to August 2019 treated in our hospital. We also assayed T-cell activation to evaluate the immune responses in these patients. Results. Fever (74.5), hepatosplenomegaly (74.5), sore throat (36.2), headache (31.9), abdominal pain (27.7), lymphadenopathy (23.4), and skin rash (6.4) were present at admission. Complications included gastrointestinal injury (25.5), neuropathy (4.3), thrombocytopenia (2.1), and splenic infarction (2.1). All patients had a good clinical course without liver failure or transition to chronic liver injury. The time to recover from liver injury ranged from 12 to 142 days (mean, 43.4±28.7 days). The serum sIL-2R level, which reflects T-cell activation, was transiently elevated and correlated with the extent of hepatic inflammation. Conclusions. CMV hepatitis in immunocompetent individuals has a satisfactory outcome, but occasionally results in complications in other organs. The sIL-2R level has potential as a surrogate marker of hepatic inflammation in immunocompetent patients with CMV hepatitis.


  • Open Access

    Therapeutic Monitoring of Class I Antiarrhythmic Agents Using High-Resolution Electrocardiography Instead of Blood Samples.

    by Igor Sutovsky, Takao Katoh, Hideo Takayama, Tadaaki Ono, Teruo Takano

    Antiarrhythmic therapy requires monitoring of serum drug concentrations to determine a patient's optimal oral dose of medication. Repeated examination of blood samples, however, is costly and time-consuming, so the present study evaluated whether changes in serum concentrations could be estimated from changes in electrocardiographic (ECG) parameters. Of 36 patients receiving antiarrhythmic drugs for supraventricular or ventricular arrhythmias, 12 were treated with flecainide, 12 with pilsicainide, and 12 with pirmenol. Signal-averaged ECG (SAECG) were recorded before starting drug administration, 1 month later, and twice during ongoing therapy. At the time of the 2nd to the 4th recordings, serum concentrations of the drugs were also measured. As previously reported, all agents, but especially flecainide and pilsicainide, prolonged the filtered QRS (f-QRS) and the duration of low-amplitude signals at the terminal portion of the QRS complex. The SAECG parameters varied between the recordings made during therapy. Differences in the duration of the f-QRS between 2 recordings correlated significantly with differences in serum drug concentrations (r=0.91 for flecainide, r=0.70 for pilsicainide, and r=0.61 for pirmenol). No significant correlation between drug concentration and other SAECG parameters was found. Changes in the serum concentration of flecainide, pilsicainide and pirmenol can be estimated from changes in the duration of the f-QRS on the SAECG and periodic monitoring of such could help reduce the number of repeat measurements of drug concentrations in blood samples. (Circ J 2003; 67: 195 - 198)